How low is too low? Experts debate blood pressure targets in post-SPRINT era: Two studies provide evidence for the benefits and costs of incorporating lower systolic blood pressure targets into clinical practice

Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in

Bloodless revolution in diabetes monitoring: Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test

Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick